SPONSOR
Huashan Hospital
Total Trials
11
Recruiting
11
Phases
Phase 2, Phase 3, EARLY_Phase 1
Conditions studied: Myasthenia GravisAtrial Fibrillation (AF)HypertensionMyasthenic CrisisDisorder of ConsciousnessTemporal Interference StimulationMultidrug Resistant TuberculosisRifampicin Resistant TuberculosisPre-XDR-TBGastric Cancer
Huashan Hospital is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Myasthenia Gravis, Atrial Fibrillation (AF), Hypertension, Myasthenic Crisis.
The trial portfolio spans Phase 2, Phase 3, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Huashan Hospital
How many clinical trials has Huashan Hospital sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Huashan Hospital, of which 11 are actively recruiting participants. These trials cover conditions including Myasthenia Gravis, Atrial Fibrillation (AF), Hypertension. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Huashan Hospital research focus on?
Huashan Hospital clinical trials span Myasthenia Gravis, Atrial Fibrillation (AF), Hypertension, Myasthenic Crisis, Disorder of Consciousness, and additional conditions. The research pipeline includes Phase 2, Phase 3, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Huashan Hospital clinical trial?
To participate in a Huashan Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Huashan Hospital trials with current recruitment status updated daily.
Clinical Trials by Huashan Hospital
NCT06241521
Recruiting
Myasthenia Gravis Registry in China
Myasthenia Gravis
NCT07482020 Phase 2
Recruiting
SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism
Atrial Fibrillation (AF)
NCT07146425
Recruiting
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
Myasthenia Gravis
NCT04837625
Recruiting
Study of Myasthenic Crisis in China
Myasthenia Gravis
NCT06896279
Recruiting
Study on the Effectiveness and Safety of Temporal Interference Stimulation in Treating Patients With Severe Consciousness Disorders
Disorder of Consciousness
NCT05081401 Phase 3
Recruiting
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)
Multidrug Resistant Tuberculosis
NCT06054906 Phase 2
Recruiting
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer
Gastric Cancer
NCT07538128 EARLY_Phase 1
Recruiting
Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
Recurrent Glioblastoma
NCT06211712
Recruiting
Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion
Acute Ischemic Stroke
NCT05965128
Recruiting
Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases
Respiratory Infectious Diseases
NCT06550622
Recruiting
Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion
Hepatitis B, Chronic
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology